ACQUISITION OF NON-CATALOGED MEDICINES GROUP M (MUSCULOSKELETAL SYSTEM) FIRST QUARTER - 2025 PROGRAMMING.- PHARMACY AND THERAPEUTICS COMMITTEE MINUTES 002 – 2025

This tender concerns the acquisition of non-cataloged medicines specifically within Group M, which pertains to the musculoskeletal system. The procurement is scheduled for the first quarter of 2025, as indicated by the 2025 programming. This acquisition is formalized through the Pharmacy and Therapeutics Committee Minutes 002 of 2025. The contracting entity responsible for this process is the CENTRO CLINICO QUIRURGICO AMBULATORIO HOSPITAL DEL DIA "MARIA ROSA PARRA ARREAGA" (CCQA-HD SAMBORONDON). The procurement procedure will be conducted via Electronic Reverse Auction (Subasta Inversa Electrónica), a modality designed to achieve competitive pricing. The specific item required under this tender is Ketorolaco, presented as a parenteral liquid solution. Each unit consists of ampoules of 2 mL, with a concentration of 30 mg/mL. The total quantity needed is 56,250 units, with an estimated value of USD 295,960.20. This tender falls under process code SIE-CCQAHDSAMBORONDON-2025-0014-1241290. The focus on non-cataloged items suggests a need for specific pharmaceutical products not typically stocked, requiring a targeted procurement effort to ensure availability for patient treatment within the specified therapeutic group.

This is a supplies contract in the governance and public administration sector. Located in Ecuador, Latin America, this opportunity is open to firms and consortiums, with an estimated budget of USD 295,960.

Published through SERCOP Ecuador, a national government procurement portal. Public procurement tenders follow the country's national bidding regulations and may have specific eligibility and documentation requirements for the supply of goods in the governance and public administration sector. Supply contracts typically require bidders to demonstrate product compliance with technical specifications, delivery capacity, and relevant certifications. This contract has already been awarded. The information is published for transparency and market intelligence purposes.